| Oct 28 |
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
|
| Oct 7 |
Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy
|
| Jul 11 |
While institutions own 21% of Akoya Biosciences, Inc. (NASDAQ:AKYA), private equity firms are its largest shareholders with 49% ownership
|
| May 29 |
We Think Some Shareholders May Hesitate To Increase Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO Compensation
|
| May 18 |
Akoya Biosciences, Inc. (AKYA) Q1 2024 Earnings Call Transcript
|
| May 14 |
Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
|
| May 9 |
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
|
| May 6 |
Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
| May 6 |
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
|
